ANTI-INTERLEUKIN 6 (IL-6) RECEPTOR ANTIBODY SUPPRESSES CASTLEMAN'S DISEASE LIKE SYMPTOMS EMERGED IN IL-6 TRANSGENIC MICE

Keywords

ImmunologyMedicineMonoclonal antibodyInterleukin-6 receptorGenetically modified mouseAntibodyInterleukinCytokineBiologyTransgene

Affiliated Institutions

Osaka University of Health and Sport Sciences JP

Related Publications

Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 but Also Interphotoreceptor Retinoid Binding Protein–Specific Th1 by Promoting Regulatory T Cells in Experimental Autoimmune Uveoretinitis

Hiroshi Haruta , Nobuyuki Ohguro , Minoru Fujimoto +7 more

PURPOSE. Both Th17 and Th1 cells contribute to experimental autoimmune uveoretinitis (EAU). Interleukin-6 (IL-6) blockade inhibits Th17 differentiation in EAU and potently suppr...

2011 Investigative Ophthalmology & Visual ... 73 citations

Interleukin-6 Receptor Blockade Selectively Reduces IL-21 Production by CD4 T Cells and IgG4 Autoantibodies in Rheumatoid Arthritis

Gustavo Carbone , Augusta Wilson , Sean A. Diehl +3 more

Interleukin-6 (IL-6) levels are known to be increased in patients with rheumatoid arthritis (RA). Tocilizumab, a monoclonal antibody to the IL-6 receptor (IL-6R), reduces diseas...

2013 International Journal of Biological S... 66 citations

Interleukin 6 Is Required for the Development of Collagen-induced Arthritis

Tonino Alonzi , Elena Fattori , Domenico Lazzaro +6 more

Interleukin-6 (IL-6) is overproduced in the joints of patients with rheumatoid arthritis (RA) and, based on its multiple stimulatory effects on cells of the immune system and on...

1998 The Journal of Experimental Medicine 605 citations

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

Chun Kwok Wong , Charles Lam , Alan Wu +8 more

SUMMARY Severe acute respiratory syndrome (SARS) is a recently emerged infectious disease caused by a novel coronavirus, but its immunopathological mechanisms have not yet been ...

2004 Clinical & Experimental Immunology 1311 citations

Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma–associated herpesvirus

Yoshiyasu Aoki , Masashi Narazaki , Tadamitsu Kishimoto +1 more

Abstract Receptor usage by viral interleukin-6 (vIL-6), a virokine encoded by Kaposi sarcoma– associated herpesvirus, is an issue of controversy. Recently, the crystal structure...

2001 Blood 72 citations

Publication Info

Year: 2002
Type: article
Volume: 20
Issue: 6
Pages: 304-311
Citations: 129
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

ANTI-INTERLEUKIN 6 (IL-6) RECEPTOR ANTIBODY SUPPRESSES CASTLEMAN'S DISEASE LIKE SYMPTOMS EMERGED IN IL-6 TRANSGENIC MICE

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

129

OpenAlex

Cite This

APA Style

                            
                                
                                    Asao Katsume, 
                                
                                    Hiroyuki Saito, 
                                
                                    Yoshiki Yamada
                                
                                et al.
                            
                            (2002). 
                            ANTI-INTERLEUKIN 6 (IL-6) RECEPTOR ANTIBODY SUPPRESSES CASTLEMAN'S DISEASE LIKE SYMPTOMS EMERGED IN IL-6 TRANSGENIC MICE. 
                            Cytokine
                            , 20
                            (6)
                            , 304-311.
                            https://doi.org/10.1006/cyto.2002.2012
                        

Identifiers

DOI: 10.1006/cyto.2002.2012